Delivery Order SPE2DB22D2009-SPE2DB25FL9RY
Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $42K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a ceiling value of $6,433.92. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is set for completion by November 10, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Dupixent (dupilumab)...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,128.38 for Dupixent 300 mg/2 ml pen injectors on July 30, 2025, with completion scheduled for July 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $25,982.33 on August 21, 2025, for the supply of Dupixent 200 mg/1.14 mL pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,862.39 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $34,236.08 on September 27, 2025, for the supply of Dupixent 300 mg/2 ml pen auto-injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a primary pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $13,555.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 200 mg/1.14 mL pen injectors. This competitively awarded, non-set-aside contract is scheduled for completion by September 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Dupixent 300 mg/2 mL pen injections. The contract, valued at $1,709.46 with a firm fixed price structure, represents a non-set-aside competitive award. Performance will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a ceiling value of $3,476.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set to be completed by November 6, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,418.92 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $18,542.26 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on July 22, 2025, with completion targeted for July 23, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery...